Manager, US Commercial and R&D
Latest From Reed Miller
The company stopped shipping Alaris in early 2020 after the FDA requested a new 510(k) for modifications and the device has been the subject of several recalls since then.
Inivata will remain a separate liquid biopsy division alongside NeoGenomics’ growing clinical, pharma and informatics divisions.
Labcorp has agreed to pay $150m in cash for Myriad Genetics’ autoimmune business, one of three major units Myriad is unloading as it tries to narrow its focus to oncology, women's health and mental health diagnostics.
Among the company's many milestones in the first quarter, the FDA approved its Therasphere radiation seed device, a major building block of the company's interventional oncology business.
In this week’s podcast, Medtech Insight's Barnaby Pickering features Finnish start-up GlucoModicum, which created a way to measure blood glucose levels without using needles. Managing editor Marion Webb discusses her latest Market Intel, which highlights three companies that developed technologies to help surgeons collaborate with remote surgical experts, including medical device specialists.
The company is expanding beyond its traditional focus on heart failure to bring its Aquadex fluid-management technology to more critical care and pediatric patients. Nuwellis’ new ticker symbol on NASDAQ is NUWE.